已收盤 04-04 16:00:00 美东时间
0.000
0.00%
Stifel's upgraded outlook on Silk Road Medical as CEO Chas McKhann addresses concerns, unveils a compelling vision, and outlines strategic initiatives. Analysts upgrade to Buy with $20 price target, citing confidence in TCAR technology and long-term growth under McKhann's leadership.
01-20 02:35
Plus Therapeutics (NASDAQ:PSTV – Get Rating) and Apollo Endosurgery (NASDAQ:APE...
2023-04-14 14:43
Pulse Biosciences (NASDAQ:PLSE – Get Rating) and Apollo Endosurgery (NASDAQ:APE...
2023-04-04 13:03
Pulse Biosciences (NASDAQ:PLSE – Get Rating) and Apollo Endosurgery (NASDAQ:APE...
2023-04-04 13:03
北京时间2023年03月07日23时17分,UFP技术(UFPT.us)股票出现异动,股价快速上涨5.06%。截至发稿,该股报113.50美元/股,成交量4....
2023-03-07 23:29
北京时间2023年03月07日22时32分,Myomo Inc(MYO.us)股票出现异动,股价急速上涨5.41%。截至发稿,该股报0.780美元/股,成交量...
2023-03-07 23:10
北京时间2023年03月07日22时33分,阿尼卡疗法(ANIK.us)股票出现异动,股价急速下跌7.20%。截至发稿,该股报26.79美元/股,成交量796...
2023-03-07 22:50
Parkman Healthcare Partners LLC raised its holdings in Apollo Endosurgery, Inc....
2023-03-07 01:53
Apollo Endosurgery, Inc. (NASDAQ:APEN – Get Rating) was the recipient of a sign...
2023-03-03 03:52
Apollo Endosurgery, Inc. (NASDAQ:APEN – Get Rating) was the recipient of a larg...
2023-02-12 17:22